Why OraSure Technologies Stock Is Soaring Today

What happened

Shares of OraSure Technologies (NASDAQ: OSUR) were soaring 15.2% as of 11:09 a.m. EDT on Monday. The big jump came after the company announced that the Food and Drug Administration granted Emergency Use Authorization (EUA) for the OMNIgene ORAL saliva collection and stabilization device used in coronavirus testing. The device was developed by OraSure's subsidiary DNA Genotek.

So what

The FDA has issued EUAs for several COVID-19 diagnostics tests so far. But this one is the first device given a green light by the FDA where patients can collect their own saliva samples without a healthcare professional being present and send the samples to a lab for testing.

Gloved hand holding swab in a person's mouth

Image source: Getty Images.

It's highly likely that the demand for testing will increase as an anticipated next wave of coronavirus outbreaks hits the U.S. The Rockefeller Foundation projects that 2.4 billion COVID-19 tests will be needed annually just in the U.S.

OraSure should have a tremendous market opportunity with OMNIgene ORAL now that it has secured an EUA. The device is already available for use in the European Union.

Now what

Other FDA decisions could be additional catalysts for the healthcare stock in the near future. OraSure hopes to soon win EUAs for its OraQuick coronavirus rapid antigen self-test and its OraSure SARS-CoV-2 antibody test. If all goes well, the company anticipates launching these products before the end of the year.

10 stocks we like better than OraSure Technologies
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and OraSure Technologies wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of September 24, 2020

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More